# Copper Metabolism Genes and SNPs
Copper biology is partly genetic.
That matters most when copper status and treatment response may be linked through the same transport pathways.
### Why these genes matter
Some of the same transporters that move copper also move platinum drugs.
That means variants or altered expression in these genes can affect both copper handling and drug response.
The strongest practical use here is not self-interpretation.
It is knowing which genes are worth flagging if you already have germline data, tumour genomics, or raw data from a consumer test.
### Key genes to know
#### SLC31A1 (CTR1)
This is the main copper importer.
It also helps import cisplatin and carboplatin.
Variants and altered expression may affect copper homeostasis, cuproptosis sensitivity, and platinum-drug entry into cells.
#### ATP7B
This is a copper exporter.
It also helps efflux cisplatin.
Higher activity or clinically relevant variants may contribute to platinum resistance in some cancers.
#### ATP7A
This is another copper exporter.
It has been linked to angiogenic signalling and may also affect treatment response patterns in selected tumour types.
#### SLC25A3 and SLC25A37
These transporters influence mitochondrial metal handling.
That makes them relevant to cuproptosis biology inside mitochondria.
#### ATOX1
ATOX1 is a copper chaperone.
It has been linked with tumour angiogenesis and copper delivery into signalling systems that support tumour growth.
### Who should pay closest attention
This is most relevant if you are:
* about to start cisplatin, carboplatin, or oxaliplatin
* already showing unusual copper accumulation during treatment
* on an anti-angiogenic regimen
* reviewing genomic data for treatment-resistance clues
### Practical use
If you already have genomic data, flag these genes for a practitioner who understands transporters and oncology pharmacology.
Do not over-interpret single SNPs in isolation.
Gene expression, tumour context, and the treatment plan matter more than raw genotype alone.
### Practical takeaway
For most people, the first step is still serum copper plus ceruloplasmin.
Gene review becomes more useful when there is a clear treatment question, especially around platinum drugs or unusual copper patterns.
### Key References
Pan-cancer genetic analysis of cuproptosis and copper metabolism
Pan-cancer analysis: copper transporters as biomarkers
Cuproptosis-related genes SLC31A1, FDX1, ATP7B in lung cancer
Copper metabolism in hepatocellular carcinoma
{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}
{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}
---
# Agent Instructions: Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter:
```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/heavy-metals-and-cancer/copper-metabolism-genes-and-snps.md?ask=
```
The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.